Jove
Visualize
Contact Us

Related Experiment Videos

Drug-resistant tuberculosis.

M Goble1

  • 1National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

Seminars in Respiratory Infections
|December 1, 1986
PubMed
Summary
This summary is machine-generated.

Managing drug-resistant tuberculosis (TB) requires careful treatment strategies. For active TB, standard regimens are recommended, while retreatment involves individualized plans based on drug susceptibility testing and patient history.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Do we need to measure total serum IgA to exclude IgA deficiency in coeliac disease?

Journal of clinical pathology·2006
Same author

Apparent exacerbation of vitiligo syndrome in a patient with pulmonary Mycobacterium avium complex disease who received clofazimine therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1996
Same author

Multidrug-resistant tuberculosis.

The New England journal of medicine·1996
Same author

Quantitative measurement of drug susceptibility of Mycobacterium tuberculosis for monitoring chemotherapy response.

Journal of the Formosan Medical Association = Taiwan yi zhi·1994
Same author

Tuberculosis therapy and alphabet soup.

Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·1993
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Drug-resistant tuberculosis (TB) presents significant global health challenges.
  • Inadequate prior treatment contributes to acquired drug resistance in TB patients.

Purpose of the Study:

  • To outline recommended management strategies for drug-resistant tuberculosis.
  • To guide the selection of effective treatment regimens for TB patients with varying resistance profiles.

Main Methods:

  • Review of current guidelines and best practices for TB management.
  • Emphasis on drug susceptibility testing and patient history for treatment individualization.

Main Results:

  • Standard multi-drug regimens are recommended for initial active TB treatment in high-prevalence areas.

Related Experiment Videos

  • Individualized retreatment regimens, utilizing previously unexposed and in vitro susceptible drugs, are crucial for acquired resistance.

    • Conclusions:

    • Effective management of drug-resistant TB necessitates tailored therapeutic approaches.
    • Ensuring patient compliance and managing adverse drug reactions are critical for successful retreatment outcomes.